The increasing prevalence of antibiotic-resistant bacteria is a global health crisis, often attributed to the misuse and overuse of antibiotics. Therefore, promoting rational use of these drugs is essential to mitigate this issue and improve patient health.
Rational use of antibiotics involves prescribing the right drug, at the right dose, for the right duration, and at the right time. It requires a balance between the benefits of treatment and potential harm, including the risk of resistance. Accurate diagnosis, based on clinical findings and, where necessary, microbiological testing, is the cornerstone of rational antibiotic use.
Antibiotic stewardship programs (ASPs) are coordinated efforts to improve and measure the appropriate use of antibiotics. ASPs can significantly reduce hospital antibiotic resistance rates and healthcare-associated infections. They involve a multidisciplinary team and incorporate clinical guidelines, education, and surveillance systems.
Education about the risks and benefits of antibiotics for healthcare professionals, patients, and the public is crucial. Effective communication between healthcare professionals and patients can help manage expectations and promote understanding of when antibiotics are necessary and when they are not.
Regulatory and policy measures can also support the rational use of antibiotics. This includes policies on antibiotic prescription, sales, and use in agriculture, as well as regulations on antibiotic promotion and access.
Addressing the challenge of antibiotic resistance requires a comprehensive approach that promotes the rational use of antibiotics in clinical practice. Through accurate diagnosis, antibiotic stewardship programs, education, communication, and supportive regulatory and policy measures, we can promote patient health and combat antibiotic resistance.
1.
Lung nodules seen in a high percentage of non-smokers
2.
Providing essential cancer care to rural communities
3.
Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women
4.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
5.
De-escalation Misses the Mark in Inflammatory Breast Cancer
1.
Adaptive Cell Therapies for Solid Tumors
2.
Mast Cell-Tumor Cell Interactions in OSCC: Genetic and microRNA Insights
3.
The Mysterious World of Petechiae: Exploring Causes and Treatments
4.
The Surprising Role of Magnesium in Digestion, Sleep and Mental Health
5.
Tumor Microenvironment Targeting: Mechanisms, Clinical Implications, and Therapeutic Advances
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
3.
Thromboprophylaxis In Medical Settings- An Update
4.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
5.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation